In the News

CABG associated with better outcomes than stents in diabetic patients

Among diabetics, coronary artery bypass grafting (CABG) was associated with lower rates of death from any cause, myocardial infarction (MI), or stroke than percutaneous coronary intervention (PCI) with a drug-eluting stent, a study found.

Low glycemic index bean diet improved HbA1c, BP

Eating at least a cup of beans per day for three months lowered diabetic patients' hemoglobin A1c (HbA1c) scores and blood pressure, a new study found.

ADA, AGS issue consensus report on diabetes in older adults

The American Diabetes Association (ADA) and the American Geriatrics Society (AGS) released a joint consensus report last month on diabetes in older adults.

MKSAP Quiz: hypoglycemic episodes and high HbA1c

This month's quiz asks readers to evaluate a 68-year-old woman with diabetes and new-onset hypoglycemic episodes.

Sulfonylureas associated with higher CV risk than metformin

As initial monotherapy for type 2 diabetes, sulfonylureas were associated with more cardiovascular events and deaths than metformin, a new study found.

Preventing and treating diabetic nephropathy

Managing kidney disease in diabetes requires meeting individualized parameters and balancing risks in nephrology and cardiology, according to experts featured in a recent article in ACP Internist.

Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes

More than 4,000 patients with type 2 diabetes, hypertension and cardiovascular disease (CVD) or CVD risk factors were randomized to a systolic blood pressure (BP) target of less than 120 mm Hg or less than 140 mm Hg.

Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes

Researchers reviewed more than 140 randomized trials of quality improvement (QI) strategies for managing adult patients with diabetes.

New drugs approved for diabetes

The first generic version of pioglitazone hydrochloride (Actos) and a new indication for ranibizumab injection (Lucentis) were recently announced by the FDA.

Give patients advice on self-monitoring their blood glucose

Recommendations for self-monitoring vary depending on the type of diabetes and treatment regimen of individual patients.

Spotlight on lifestyle interventions for National Diabetes Month

World Diabetes Day is to be held on Nov. 14 and President Obama recently proclaimed November to be National Diabetes Month.